Disponibilidade de medicamentos e insumos para controle glicêmico de pacientes com diabetes mellitus tipo 2

Abstract

To evaluate the availability of antidiabetic medications in Primary Health Care Units (UBS) in Teresina, Piauí, Brazil. Methodology: Six UBS affiliated with the State University of Piauí (UESPI) were visited by the researchers, who applied a specific data collection instrument. During the visits, the staff member responsible for the pharmacy was interviewed regarding the availability or absence of various medications and supplies for glycemic control in patients with type 2 diabetes mellitus (T2DM), listed in the 2024 National List of Essential Medicines (RENAME). Results: Adequate glycemic control, through the combination of lifestyle modifications and pharmacological treatment, is essential for preventing complications. However, in Brazil, there is limited adherence to lifestyle changes, making the use of medications indispensable. A frequent shortage of gliclazide was identified in the primary health care units, whereas other medications and supplies for self-monitoring of blood glucose were consistently available. Conclusion: The study found that the main drugs used for glycemic control were available in the UBS evaluated.